Novel Method Combines Heart Biopsy and Device Implantation to Reduce Risk of Complications

Researchers have developed an innovative method that integrates right ventricular (RV) septal endomyocardial biopsy (EMB) with the implantation of cardiac implantable electronic devices (CIEDs), such as pacemakers or defibrillators. This new technique utilizes a single 3D curved conduction system pacing (CSP) sheath for both procedures, potentially reducing the risk of complications associated with traditional invasive methods.

Endomyocardial biopsy is a critical procedure for diagnosing various cardiac conditions but carries inherent risks due to its invasive nature. By using the same CSP sheath for both EMB and subsequent CIED implantation, this novel approach not only streamlines the process but also minimizes tissue trauma and the likelihood of complications.

This advancement represents a significant step forward in cardiac care, promising safer diagnostic and treatment options for patients requiring detailed heart tissue analysis and rhythm regulation.

Newsflash | Powered by GeneOnline AI

Related posts:

Breakthrough Discovery: Key Protein Could Enable Human Heart Regeneration Access to Free COVID-19 Tests in the United States How the Brain Rewires Itself for Language Recovery After a Stroke Groundbreaking Study Reveals How Aging Heart Influences Brain Function

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline